The nurse is preparing to administer an inhaled corticosteroid to a client. Which condition in the client's medical history should cause the nurse to monitor the client more closely while on this medication?

A. Sulfa allergy: Inhaled corticosteroids are not sulfonamide-based medications, so a history of sulfa allergy does not increase the risk of adverse effects. Monitoring for allergic reactions related to sulfa is not necessary. B. Diabetes mellitus: Inhaled corticosteroids can increase blood glucose levels by promoting gluconeogenesis and reducing insulin sensitivity. Clients with diabetes are at risk for hyperglycemia, so closer monitoring of blood glucose is essential while on this medication. C. Asthma: Asthma is an indication for inhaled corticosteroids rather than a risk factor for adverse effects. While monitoring for effectiveness is important, asthma itself does not necessitate additional safety monitoring beyond standard care. D. Cataracts: Long-term systemic corticosteroid use is associated with an increased risk of cataracts, but inhaled corticosteroids have a much lower systemic absorption. While eye exams may be part of long-term care, immediate close monitoring is not typically required for cataracts.